AddLife AB (publ) (ALIF-B.ST)
Supplies laboratory instruments, medical devices, and diagnostic equipment to hospitals, research facilities, and industries.
161.20+0.02%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago-5.0%
The outlook
AddLife trades at 161.2 SEK, sitting comfortably above both its 50- and 200-day moving averages and roughly midway through its 52-week range. Analyst consensus is unanimously Strong Buy, with the average price target implying roughly 23% upside from current levels. The stock carries a trailing P/E of 33, reflecting investor expectations for growth.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 3 analysts
Price trendAbove its 50- & 200-day averages
52-week range40% of the way from its 52-week low to high
Price targetAvg target +23% vs current price
Analyst price target
~12-month · 3 analysts198.33average target+23.0% vs now
Now 161.20
Low 185.00High 205.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$19.64B
52-wk high
208.40
52-wk low
130.20
50-day avg
157.71
200-day avg
158.91
Trailing P/E
33.0